BETHESDA, MD (May 27, 2005) - United BioSource Corporation (UBC), a leading provider of comprehensive evidence-based drug evaluation services, today announced that Dr. Bryan R. Luce has been invited to serve as a member of the Medicare Coverage Advisory Committee (MCAC). Dr. Luce is the Scientific Policy Director and founder of The MEDTAP Institute, the scientific research arm of UBC. 

"I am honored to contribute to this important group and help guide our nation's Medicare policy," said Dr. Luce. "As the emphasis on evidence-based medicine continues to grow, especially in light of the Medicare Modernization Act, the government is under greater pressure to make informed and supportable coverage decisions. UBC and The MEDTAP Institute have become industry leaders in exactly this sort of evaluation, so our expertise should be very useful to the Committee."

Dr. Bryan Luce has spent many years as a health care industry executive, and has served as a consultant to numerous government agencies as well as pharmaceutical and device firms worldwide. From 1995 to 2002, Dr. Luce was Chairman, President and CEO of MEDTAP. Previously, he held positions as the Director of Battelle's Centers for Public Health Research and Evaluation, Director of the Office of Research and Demonstrations at the Health Care Financing Administration, and Senior Analyst in the former Congressional Office of Technology Assessment.

Luce will serve on the MCAC for a period of two years beginning in the summer of 2005. The MCAC advises the Centers for Medicare and Medicaid Services (CMS) on whether specific medical items and services are reasonable and necessary under Medicare law. It performs this task through a careful review and discussion of specific clinical and scientific issues, and it does so in an open and public forum. MCAC members are valued for their background, education and expertise in a wide variety of scientific, clinical and other related fields.


United BioSource Corporation (UBC) delivers evidence-based solutions to optimize the medical and commercial potential of pharmaceuticals, biotechnology, medical devices, and diagnostics. UBC is based in Bethesda, Maryland. For more information about UBC, visit 

News

Health Care Industry Executive and Consultant Dr. Bryan R. Luce Will Help Guide Medicare Policy Over the Next Two Years